AMR |
antimicrobial resistance |
ATF |
ambient temperature fimbria |
BIA |
biolayer interferometry assay |
CAUTIs |
catheter-associated UTIs |
CBD |
carbohydrate binding domain |
CBS |
carbohydrate-binding site |
CD-based HMs |
cyclodextrin-based heptyl mannosides |
CTD |
C-terminal domain |
CU |
chaperon-usher |
DSF |
differential scanning fluorimetry |
ECDC |
European Center of Diseases Prevention and Control |
ELISA |
enzyme-linked immuno sorbent assay |
Fim3 |
Fimbria 3 |
FPA |
fluorescence polarization assay |
IBCs |
intracellular bacterial communities |
ITC |
isothermal titration calorimetry |
MBP |
mannose-binding pocket |
MBS |
mannose-binding site |
MDR |
multi-drug-resistant |
MeMan |
Methyl α-d-mannoside |
MR/P |
mannose-resistant Proteus-like |
MR/K |
mannose-resistant Klebsiella-like |
NAF |
non-agglutinating fimbria |
NTD |
N-terminal domain |
PACs |
proanthocyanidins |
pap
|
pyelonephritis-associated pili |
PDR |
pan-drug-resistant |
PMF |
P. mirabilis fimbria |
PMP |
P. mirabilis P-like pili |
RIP |
relative inhibitory potency |
RLA |
radioactive labeling assay |
rUTI |
recurrent UTI |
SPR |
surface plasmon resonance |
UCA |
urothelial cell adhesin |
UTI |
urinary tract infection |
UPEC |
uropathogenic Escherichia coli
|
UPKP |
uropathogenic Klebsiella pneumoniae
|
UPPM |
uropathogenic Proteus mirabilis
|
UPs |
uroplakins |